drugset

drugset / Trial / NCT07589257

A Study of VRT106 in Combination With Radiotherapy in Adult Patients With Diffuse Midline Glioma / Diffuse Intrinsic Pontine Glioma

NCT07589257 ↗

Phase 2 Recruiting 10 enrolled Guangzhou Virotech Pharmaceutical Co., Ltd.

NaSingle-groupOpen-labelTreatment

Summary

To Evaluate the Preliminary Efficacy and Safety/Tolerability of VRT106 Combined with Radiotherapy in Adult Patients with DMG/DIPG

Timeline

Start: 2026-05-07
Primary completion: 2028-06-30
Completion: 2028-12-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	VRT106	Unknown	—	Intravenous

Indications